Primary results from OCEANIC-STROKE: asundexian for secondary stroke prevention скачать в хорошем качестве

Primary results from OCEANIC-STROKE: asundexian for secondary stroke prevention

Mike Sharma, MD, MSc, FRCPC, McMaster University, Hamilton, Canada, shares the primary results from the OCEANIC-STROKE trial (NCT05686070) of asundexian for secondary stroke prevention following acute ischemic stroke or high-risk transient ischemic attack. Prof. Sharma highlights a significant reduction in the risk of another ischemic stroke with no increase in bleeding, with a consistent effect across all subgroups. This interview took place at the 2026 International Stroke Congress (ISC), held in New Orleans, LA. These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.